approval
saveNAPROXEN — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalALDACTAZIDE: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSep 30, 2025
- approvalALDACTAZIDE: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalSep 30, 2025
- approvaltopiramate ER: TOPIRAMATE — FDA approvalOct 7, 2025
- approvalolanzapine ODT: OLANZAPINE — FDA approvalOct 23, 2025
- approvalondansetron hydrochloride CR: ONDANSETRON HYDROCHLORIDE — FDA approvalOct 23, 2025
- approvalLINAGLIPTIN: LINAGLIPTIN — FDA approvalNov 3, 2025
🐶 often sniffed alongside
top 8- tagApproval204 co-mentions · 97 sources
- drugALEVE176 co-mentions · 97 sources
- drugNaprogesic176 co-mentions · 97 sources
- drugnaproxen DR113 co-mentions · 98 sources
- drugNAPROXEN SODIUM112 co-mentions · 97 sources
- drugnaproxen sodium ER112 co-mentions · 97 sources
- tagSmall Molecule102 co-mentions · 97 sources
- drugsumatriptan10 co-mentions · 5 sources
comments(0)
5-min edit window · permanent after that